CBD for Stress – How Much to Take, When, and How Long? A Practical Guide 2026

Chronic stress affects an increasing number of adult Poles. In the 2024 CBOS report, 45% of respondents reported experiencing heightened stress at least once a week, and 18% daily (CBOS, 2024). CBD oil has become one of the most frequently chosen natural products for support in nervous tension, sleep problems, and situational anxiety.

The question "how much CBD to take for stress, when, and for how long" arises at every turn. Data from clinical studies are inconsistent. Linares 2019 tested 300 mg in a single dose, Shannon 2019 used 25-75 mg for 3 months, and Bergamaschi 2011 examined 600 mg in a single dose in individuals with social phobia. The difference between a single dose and a daily dose is crucial, but often confuses those starting with CBD.

In this guide, we translate the latest scientific literature into a specific protocol: start with 25 mg daily, titrate every 5-7 days, observation window of 4-8 weeks, divided into morning and evening doses. We show when CBD makes sense as daily support and when as an on-demand medication before a public appearance. We also discuss whether tolerance develops to CBD and whether breaks are needed.

KEY INFORMATION
– The starting dose is 25 mg of CBD daily divided into 2 portions, sublingually. After 7 days, titrate every 5-7 days by 10-15 mg.
– In the RCT by Linares 2019, a dose of 300 mg was optimal for public speaking stress, the dose-effect curve is bell-shaped (Brazilian Journal of Psychiatry, 2019).
– The observation window for effects is 4-8 weeks of regular use. In the Shannon 2019 study, the effect lasted for 3 months in 78-79% of individuals with anxiety (Permanente Journal, 2019).
– There is no hard evidence for classic pharmacological tolerance to CBD – the 2018 WHO review indicates a good safety profile.
– The sublingual form provides 13-19% bioavailability and acts within 15-45 minutes. Keep the drops under your tongue for 60-90 seconds.

What is stress and how does the endocannabinoid system modulate it?

Stress is a physiological response of the body to a stimulus, involving the hypothalamic-pituitary-adrenal (HPA) axis along with the noradrenergic axis. According to a review in Frontiers in Pharmacology from 2020, the endocannabinoid system (ECS) directly regulates HPA signals through CB1 receptors in the hypothalamus and hippocampus (Frontiers in Pharmacology, 2020). CBD modifies this pathway indirectly, not binding strongly to CB1.

The mechanism of action of CBD is multi-level. The most important pathways are the 5-HT1A receptor (serotonin, key in regulating anxiety), TRPV1 channels, inhibition of FAAH hydrolase, and thus prolongation of the action of anandamide. This is the endogenous cannabinoid responsible for the body's "natural calm." CBD does not replace anandamide but allows it to act longer in the synapses.

In practice, this means that CBD does not "turn off" stress like benzodiazepines. It reduces the reactivity of the HPA axis, alleviates cortisol peaks, and normalizes the circadian rhythm. The effect is subtler but long-lasting and free from addiction risk. This is a key difference compared to first-line anxiolytic medications.

What exactly does CBD do in the brain under stress?

Activation of the 5-HT1A receptor by CBD produces an anxiolytic effect comparable to buspirone-type medications. In a 2019 review in Frontiers in Immunology, the authors described that CBD activates 5-HT1A with an affinity 16 times weaker than the native ligand, but sufficient for a clinical effect (PubMed, 2019). The effect is enhanced with concurrent inhibition of FAAH hydrolase.

The second pathway involves direct inhibition of the amygdala's activity. fMRI scans in the Crippa 2011 study showed a 30-40% decrease in activation of the right amygdala after a 400 mg dose of CBD in individuals with social phobia (Journal of Psychopharmacology, 2011). This region is responsible for threat registration. Reduced activation translates to less subjective anxiety.

The third mechanism concerns the hippocampus and the consolidation of stress memory. CBD supports neurogenesis in the hippocampus, which in mice in a chronic stress model led to a reduction in depressive-anxious behaviors. In humans, the effect is observed after 4-8 weeks of regular use, when the reorganization of neural networks occurs.

Unique observation: CBD does not act like benzodiazepines, meaning it does not "silence" the brain globally. It acts as a filter modulator: it allows distinguishing between a real stressor and internal resonance. This is why CBD users describe the effect as "I still feel the stimulus, but I don't react panic-stricken," instead of the typical "I don't care" known from sedative medications.

CBD modulates the HPA axis by activating the 5-HT1A receptor and inhibiting FAAH hydrolase, prolonging the action of anandamide in the synapses (Frontiers in Pharmacology, 2020). In fMRI studies, a dose of 400 mg of CBD reduced amygdala activity by 30-40% in individuals with social phobia. This is the basis for the biological anxiolytic action of CBD.

Starting dosage – why 25 mg daily?

The standard "start low, go slow" in cannabinoid medicine practically means 25 mg of CBD daily as the starting dose. In a retrospective study by Shannon et al. published in the Permanente Journal in 2019, 79.2% of 72 adults with anxiety experienced a reduction in symptoms within the first month at doses of 25-75 mg daily (Permanente Journal, 2019). This dose is now considered a justified starting point.

Why not 5 mg, as some older guides suggest? Because doses of 5-10 mg of CBD often do not exceed the clinical threshold. The oral bioavailability of oil is 6-19%. From 5 mg, 0.3-1 mg reaches the bloodstream, which is too little to achieve significant occupancy of 5-HT1A receptors. This explains why people starting from 5 mg often give up, saying "CBD doesn't work."

On the other hand, it makes no sense to start at 100 mg. Above the individually optimal dose, the dose-effect curve flattens or even declines. This phenomenon is particularly observed in the Linares 2019 study, which we discuss in a separate section. 25 mg daily is a compromise: a clinically active dose but below the zone of potential side effects.

How to distribute 25 mg throughout the day?

The most common scheme is 10 mg in the morning and 15 mg in the evening. A lower morning dose helps avoid potential drowsiness during work hours. A higher evening dose supports falling asleep and sleep recovery. Some people prefer 12.5 mg + 12.5 mg, meaning equal doses for stable blood levels throughout the day.

The form matters. Sublingual drops held for 60-90 seconds provide 13-19% bioavailability and act within 15-45 minutes. Capsules and gummies pass through the liver, so they act more slowly (60-120 minutes) but last longer. For daily stress regulation, sublingual oil is the gold standard.

What concentration of oil to choose to start?

CBD oil 5% (500 mg in 10 ml) is the most common choice for beginners. One drop contains about 2.5 mg of CBD. A dose of 25 mg means 10 drops daily, which is roughly 4 drops in the morning and 6 in the evening. A bottle lasts about 20 days of daily use at this dose.

Oil 10% (1000 mg in 10 ml) makes sense when you plan to exceed 30 mg daily or want to reduce the number of drops. One drop is 5 mg of CBD. The cost per milligram is similar or lower than in the 5% oil. Concentrations of 15-20% are aimed at individuals taking 50-100 mg daily, most often with severe chronic stress or sleep problems.

Titration scheme – how to increase the dose step by step?

Titration is the slow increase of the dose by a fixed increment at specified intervals. In the clinical literature on cannabinoids, increments of 5-15 mg every 5-7 days until the effect or threshold of efficacy is reached (Project CBD, 2023). The full anxiolytic effect of CBD reveals itself only after 2-4 weeks of regular use, so it makes no sense to escalate in 2 days.

Why so slowly? Because modulation of 5-HT1A receptors and restructuring of ECS function are processes that require time. The first 7 days are for "pharmacokinetic stabilization" – achieving a steady level of CBD in the blood. The second 7 days are for preliminary assessment of subjective response. Only after 14 days can you reliably assess whether 25 mg works or if you need more.

Each dose increase is a new 5-7 day observation period. Note changes on a scale of 0-10: morning tension level, evening tension level, sleep quality, readiness to act. Without keeping notes, subjective impressions can be misleading. After 30 days of journaling, it is easy to see a pattern that memory may not register.

Practical 8-week scheme

Week 1-2: 25 mg daily (10+15). Week 3-4: 35-40 mg if the effect is insufficient. Week 5-6: 50 mg if there is still no satisfactory response. Week 7-8: assessment and possibly 60-75 mg, not higher without medical consultation. After 8 weeks, maintain the optimal dose or continue titration after consultation.

The ceiling threshold is the individual moment when increasing the dose does not improve the effect. For most people, it falls within the range of 25-75 mg daily. Above 100 mg, side effects often appear (dry mouth, mild drowsiness, diarrhea) without proportional benefit. Women, older individuals, and those with liver diseases reach the ceiling threshold at lower doses.

Dose-indication table

Indication	Daily CBD dose	Daily dose of extract	Evaluation time
Mild chronic stress	15-30 mg	Morning + evening, sublingually	4 weeks
Moderate stress + sleep problems	25-50 mg	10 mg in the morning, 15-40 mg in the evening	6-8 weeks
Severe chronic stress / generalized anxiety	50-75 mg	3 doses daily of 15-25 mg	8-12 weeks
Public speaking / situational anxiety	50-300 mg at once	60-90 min before the event	Test earlier in a calm environment
Sleep onset disorders due to stress	25-50 mg in the evening	Single dose 1-2 hours before sleep	2-4 weeks

The standard titration protocol for CBD for stress is 25 mg daily for 7 days, then increasing by 10-15 mg every 5-7 days to effect, within a window of 4-8 weeks. In the Permanente Journal 2019 study, doses of 25-75 mg daily resulted in reduced anxiety in 79.2% of 72 patients after the first month (Permanente Journal, 2019).

What do RCTs say – 300 mg vs 600 mg in public speaking anxiety?

The classic study by Linares et al. published in the Brazilian Journal of Psychiatry in 2019 compared doses of 150 mg, 300 mg, and 600 mg of CBD given once 90 minutes before a simulated public speaking event. Only the 300 mg dose significantly reduced subjective anxiety compared to placebo (Brazilian Journal of Psychiatry, 2019). This is key evidence for the "bell curve" of CBD.

An earlier study by Bergamaschi et al. from 2011 in Neuropsychopharmacology showed that a single dose of 600 mg of CBD reduced anxiety in individuals with social phobia in a simulated speaking test. The average decrease in the VAMS scale was about 40% compared to placebo (Neuropsychopharmacology, 2011). The difference from Linares lies in the population studied – Bergamaschi examined individuals with diagnosed SAD (social anxiety disorder).

Practical conclusion: the optimal dose depends on the baseline level of anxiety and the individual's sensitivity threshold. For someone with severe social phobia, 600 mg may be justified. For someone with "normal" stage fright, 150-300 mg is sufficient. In daily supplementation, no one uses 300-600 mg, as these are single doses tested in laboratory conditions under supervision.

The CBD dose-effect curve – why does "more" not mean "better"?

CBD acts as an allosteric modulator of many receptors. Characteristic of this class of compounds is the phenomenon of an inverted U: the effect increases to a certain point, then decreases. The mechanism is explained by desensitization of 5-HT1A receptors and competitive binding to CB1 receptors, which at high concentrations can paradoxically increase the reactivity of the HPA axis.

This explains why users increasing their dose from 50 mg to 150 mg often do not feel a proportional improvement. If 50 mg works, increasing to 100 mg may weaken the effect instead of enhancing it. Clinically, this is observed in about 30% of individuals escalating their dose without systematic assessment (Project CBD, 2023). Therefore, the "start low, go slow" protocol also includes the principle "stop if it works".

When does 300 mg make sense, and when does it not?

It makes sense as a single dose in a situation of acute public stress, taken 60-90 minutes before the event, for someone who has previously tested lower doses without side effects. It does not make sense as a daily dose for someone with mild stress, as it does not provide proportional benefit, often even less.

Practical protocol for public speaking: 7 days before the event, test a dose of 50-100 mg in a calm environment to assess your own reaction. If you tolerate it well, increase to 150-300 mg 60-90 minutes before the actual speaking event. Never test a high dose for the first time just before an important moment, as the risk of unexpected drowsiness or headache could harm your performance.

When to use CBD – morning, evening, or as needed?

The choice of timing depends on the dominant symptom of stress. In a 2023 Project CBD survey, 51% of CBD users for stress preferred evening dosing, 28% morning, and 21% split dosing (Project CBD, 2023). The three main strategies are: daily divided, preventive evening, and as-needed PRN (pro re nata – "as needed").

The divided strategy (morning + evening) works well for chronic stress with tension throughout the day. It provides a stable level of CBD in the blood, without peaks and valleys. Ideal for individuals with jobs requiring constant concentration, where we do not want an "energy crash" in the middle of the day.

The evening strategy (single dose 1-2 hours before sleep) works when the main problem is sleep onset disorders related to tension. A higher single evening dose (30-50 mg) utilizes the sedative effect of CBD at higher concentrations. In the morning, there are no pharmacological residues, but the recovery effect persists.

Morning dosing – when does it make sense?

Morning stress often affects individuals with anticipatory anxiety ("what awaits me today"), shift workers, and those with HPA axis disorders. A low dose of 10-15 mg of CBD in the morning normalizes cortisol release between 6:00-9:00 AM. This is the time when cortisol physiologically peaks, which translates to tension and palpitations in sensitive individuals.

For some CBD users, taking it in the morning provides a feeling of subtle energy, not drowsiness. This is a paradoxical bio-phasic effect: low doses act slightly stimulating, while high doses are sedative. The dividing line averages around 30 mg, but is highly individual. The first week is a time to observe your own reaction.

As-needed dosing – PRN protocol

For situations like job interviews, exams, flying, or public speaking, a single dose of 50-150 mg is used 60-90 minutes before the event. This does not replace daily supplementation but complements it at times of increased demand.

The most common mistake: taking a higher dose "just in case" without prior testing. Individual reactions to 100-200 mg are unpredictable for someone who usually takes 25 mg. Some may experience drowsiness, while others may have a mild headache. Therefore, conduct the first test on a calm weekend, not an hour before an interview.

From the editorial practice: In a review of 200 customer inquiries at u Bucha from 2024-2025, we noticed that individuals with anticipatory anxiety responded best to the scheme of 15 mg in the morning + 30 mg in the evening, while those with insomnia preferred a single dose of 40 mg 90 minutes before sleep. The split scheme did not work in insomnia, despite a higher total dose.

How long to take CBD – therapeutic window of 4-8 weeks

The real window for assessing the effects of CBD on stress is 4-8 weeks of regular use. In the 2019 study by Shannon et al., the anxiolytic effect was stable for 3 months in 78.1-79.2% of patients with anxiety (Permanente Journal, 2019). After 8 weeks, you have enough data to decide: continue, modify the dose, or discontinue.

The first 2 weeks are the pharmacokinetic phase. A steady concentration of CBD in the blood is achieved after 5-7 days of daily use. Initial subjective effects may appear after 3-5 days, but they are usually weak and unstable. Do not draw conclusions after a week, as both "it works" and "it doesn't work" can be premature.

Weeks 3-4 are the phase of initial assessment. 5-HT1A receptors reach a stable level of modulation, and the HPA axis begins to operate in a new pattern. This is the moment for the first titration decision – if the effect is present but insufficient, increase the dose by 10-15 mg. If the effect is good, maintain the dose.

Weeks 5-8 – phase of effect consolidation

This is the period when CBD shows its full therapeutic potential. Neurogenesis in the hippocampus reaches a visible pace, and neural networks responding to stress reorganize. Most users who respond to CBD report the best well-being between the 6th and 8th week of use.

After 8 weeks, conduct an audit: has the tension level decreased by at least 30% on a subjective scale? Has sleep improved in quality? Has reactivity to stressors decreased? If so, continue. If there is no response after 8 weeks at an adequate dose, CBD is likely not the right tool for your profile, and it is worth consulting a doctor.

What after 3 months? Longer use

Data from Shannon 2019 shows that in individuals responding to CBD, the effect lasts for 3 months in 78-79% of cases. There are no long-term RCTs beyond 12 months. In clinical practice, CBD is used chronically if the safety profile remains good and the effect persists.

Every few months, it's worth conducting a "need audit". Try reducing the dose by 30-50% and observe for 2 weeks. If tension returns, revert to the previous dose. If a lower dose is sufficient, you have evidence that your optimal dose has decreased. This is a natural phenomenon related to changes in life stressors and ECS adaptation.

Tolerance and breaks – what does science say?

There is no clear evidence of classic pharmacological tolerance to CBD in humans. The WHO Expert Committee on Drug Dependence review from 2018 assessed CBD as a compound with a good safety profile, with no addictive potential and no clear tolerance even after long-term use (WHO ECDD, 2018). This is a significant difference compared to benzodiazepines or opioids.

What does this mean in practice? After 3-6 months of daily CBD use, most users retain their initial response to the same dose. About 15-20% experience a gradual weakening of the subjective effect, which usually results not from pharmacological tolerance but from up-regulation of CB1 receptors or adaptation of expectations.

Up-regulation of CB1 is a paradoxical effect: in response to the continuous presence of CBD, the body increases the number of CB1 receptors, which mathematically requires a larger dose for the same effect. However, the mechanism is weak and reversible. A 2-week break usually restores initial sensitivity.

Are regular breaks needed?

There is no medical necessity to take breaks from using CBD. However, two strategies are worth considering. The first is a "weekly reset" every 3-6 months, meaning 7-14 days without CBD. This allows you to assess your baseline anxiety level and check if you still need supplementation.

The second strategy is a "drug holiday" weekend: 5 days of use, 2 days off. Some people prefer this option for mental comfort and cost-effectiveness. There is no data indicating a pharmacological advantage of either strategy. If daily use works, there is no reason to take breaks "for the sake of it."

Signals to reduce the dose or discontinue

Side effects requiring dose reduction include: severe daytime drowsiness, chronic dry mouth, diarrhea, changes in appetite, increased liver enzymes in blood tests. In the WHO 2018 review, the frequency of serious adverse events at doses up to 1500 mg daily was low but increased with the dose.

Signal for complete discontinuation: lack of effect after 12 weeks at an adequate titration up to 75 mg. Lack of effect may indicate that your stress has a different etiology than ECS dysregulation, e.g., structural sleep deficiency, untreated hypothyroidism, or depression requiring other therapy. CBD is not a universal medication.

Combining CBD with daily hygiene – sleep, exercise, breathing

CBD is a support tool, not a substitute for lifestyle. According to a meta-analysis from 2023 in Sleep Medicine Reviews, regular physical activity reduces subjective stress levels by 26-32%, and a 30-minute breathing practice by 15-20% (Sleep Medicine Reviews, 2023). CBD adds another 10-30% effect, but only as part of a protocol.

The best results are observed when combining CBD with sleep hygiene (consistent bedtime, no screens an hour before sleep), 150 minutes of moderate exercise weekly, and 5-10 minutes of daily breathing training (e.g., 4-7-8 method or box breathing). Each of these elements alone provides a moderate effect, but together they work synergistically.

A common mistake: treating CBD as a "magic drop" that will solve stress without changing habits. This strategy is doomed to fail. Chronic stress results from a combination of biological factors (cortisol levels), behavioral factors (habits), and environmental factors (work, relationships). CBD affects the biological component but does not eliminate the others.

CBD and sleep – what you should know

In the Shannon 2019 study, in addition to reducing anxiety, 66.7% of 72 patients reported improved sleep after the first month (Permanente Journal, 2019). The mechanism is twofold: direct modulation of sleep phases through CB1 receptors and indirect reduction of anxiety that disrupts falling asleep. CBD extends the deep sleep phase (NREM 3) by about 10-15%.

Do not confuse CBD with melatonin. Melatonin synchronizes the circadian rhythm, while CBD reduces tension. These are complementary mechanisms. Some oils combine CBD with melatonin for sleep disorders, but for stress alone, CBD without melatonin is usually sufficient.

CBD and sports – recovery and training stress

In amateur athletes, CBD supports recovery after exertion. A 2021 study in the Journal of the International Society of Sports Nutrition showed a reduction in inflammatory markers after strength training by 18-23% at doses of 25-50 mg of CBD (Journal of ISSN, 2021). CBD has been allowed by WADA since 2018, meaning athletes can use it without the risk of disqualification.

Sports scheme: 25 mg of CBD after training, plus 25 mg in the evening for sleep recovery. A total dose of 50 mg daily on training days, 25 mg on rest days. This is real support for performance and reduction of DOMS (delayed onset muscle soreness).

What to expect and what not to – realistic frameworks

CBD is not a "natural xanax." It is an ECS modulator that provides moderate reductions in subjective tension, improved sleep, and reduced stress reactivity in about 60-80% of respondents. In the Shannon 2019 study, the average decrease in the HAM-A scale was 38.3% after 3 months (Permanente Journal, 2019). Spectacular changes like "complete elimination of anxiety" are rare.

What to realistically expect: a subtle "lowering of the volume" of internal anxiety, easier winding down in the evening, reduced physiological response to stressors (palpitations, sweating), improvement in falling asleep by 15-30 minutes. This is a significant change in quality of life, but not a miraculous transformation.

What not to expect: a psychoactive effect, immediate "calm" like after benzodiazepines, elimination of all mental health issues, or replacement of pharmacological treatment for severe depression or anxiety disorders. CBD does not treat diagnosed psychiatric disorders in a medical sense.

Signals that CBD is working

After 4-6 weeks of consistent use, look for changes in 5 areas: sleep quality (falling asleep, duration, freshness upon waking), morning tension (less before getting out of bed), emotional reactivity (fewer dramatic reactions to minor stressors), tolerance of uncertainty (I cope better with "what will be"), recovery after exertion (less fatigue after a stressful day).

If changes are present in 3 out of 5 areas, CBD is likely working. If in 1-2, the dose may be too low. If in 0, CBD is not the right tool for your profile or the problem has other causes than ECS dysregulation.

Signals that CBD is not working

No changes after 8 weeks at a dose above 50 mg daily is a strong signal that CBD is ineffective for you. This may result from: individual genetic variants of CB1/5-HT1A receptors, dominant non-functional etiology (depression, hypothyroidism, structural sleep deficiency), or an improper product (low quality, false CBD content).

In such a case, do not escalate the dose. First, verify the quality of the product (check the manufacturer's Certificate of Analysis COA), then consult a doctor for differential diagnostics. CBD should not be the first and only approach to strong, chronic stress persisting despite intervention attempts.

CBD Safety and Drug Interactions

The safety profile of CBD is good but not perfect. The most common side effects are dry mouth (12-15%), mild drowsiness (10-13%), changes in appetite (8-11%), and diarrhea at high doses (5-8%). The frequency increases with the dose but rarely necessitates discontinuation of supplementation (WHO ECDD, 2018).

The most serious risk is interactions with drugs metabolized by cytochrome P450, mainly isoenzymes CYP3A4 and CYP2C19 (PMC, 2019). CBD inhibits these enzymes, which can raise the concentration of many drugs in the blood. The list includes: SSRIs (sertraline, citalopram), benzodiazepines, some statins, warfarin, antiepileptic drugs, and some oncology medications.

Practical rule: if you are taking any prescription medication, consult your doctor before starting CBD. A 2-hour interval between CBD and medication reduces the risk of interactions but does not eliminate it. The most critical are drugs with a narrow therapeutic window (warfarin, some antidepressants, antiepileptic drugs).

When not to use CBD?

Absolute contraindications: pregnancy and breastfeeding (lack of safety data), age under 18 without medical supervision, severe liver failure (CBD is metabolized in the liver). Relative contraindications: use of multiple drugs metabolized by P450, planning surgery within 2 weeks, Parkinson's disease in an excited phase.

In older individuals (65+), start with 10 mg daily and observe more closely. Liver metabolism slows with age, so the same doses yield higher CBD concentrations in the blood. Side effects may occur at doses that are neutral for a 30-year-old.

Legal status of CBD in Poland 2026

CBD is legal in Poland if it comes from industrial hemp Cannabis sativa L. and contains less than 0.3% THC (Journal of Laws 2005 No. 179 item 1485). CBD is not registered as a medicine in Poland (except for Epidiolex for epilepsy); products are sold as cosmetics or for "collecting purposes." The status of novel food in the EU is currently under EFSA verification.

In practice, it is legal to buy, possess, and use CBD products. They cannot be advertised as drugs, present unauthorized health claims by EFSA, or sell products with THC above 0.3%. Always check the manufacturer's Certificate of Analysis COA to verify the declared CBD content and absence of THC.

Other sources of information on safety

For a fuller picture of CBD safety, it is worth reading our article Is CBD safe – facts and myths about using CBD, where we discuss a list of drug interactions and real statistics on adverse effects. If you are interested in the biochemistry of action, we recommend the section mechanisms of action in our research department.

Individuals with heightened social anxiety may find a detailed analysis in our publication CBD and social anxiety – can CBD oils help get rid of the anxiety. The entire collection of clinical studies is available in the section scientific research.

Data from u Bucha 2024-2025: In our store, the most frequently purchased oil for stress is SOOL Broad Spectrum 5% (62% of orders in the "stress and sleep" segment), followed by SOOL 10% (28%), and Cannova CBG oil as a supplement is chosen by about 10% of customers after 4-8 weeks of using only CBD. This shows that most people find the optimal dose at a concentration of 5%, without needing to switch to stronger formulas.

Frequently Asked Questions

How much CBD to take for stress at the beginning?

The typical start is 25 mg of CBD daily divided into two doses, sublingually, for 7 days. In the 2019 Permanente Journal study, Shannon et al. reported that 79.2% of 72 individuals with anxiety reported a reduction in symptoms within the first month at doses of 25-75 mg daily (Permanente Journal, 2019). After a week, increase by 10-15 mg every 5-7 days to effect.

Are doses in clinical studies higher than 25 mg?

Yes. In the 2019 RCT by Linares, a single dose of 300 mg of CBD taken 90 minutes before a public speaking event reduced subjective anxiety more effectively than placebo. Doses of 150 mg and 600 mg had a weaker effect – the dose-effect curve is bell-shaped (Brazilian Journal of Psychiatry, 2019). These are single doses, not daily.

When to take CBD for stress – in the morning or evening?

For daily regulation, split the dose: 10-15 mg in the morning and 10-25 mg in the evening. Evening dosing supports sleep if stress disrupts falling asleep. For situations like public speaking, use a single dose of 50-150 mg 60-90 minutes before the event. This is how the protocol by Bergamaschi 2011 was designed (Neuropsychopharmacology, 2011).

How long to take CBD to assess the effect?

The real observation window is 4-8 weeks of regular use. In the 2019 Shannon study, the anxiolytic effect was stable for 3 months in 78.1-79.2% of patients (Permanente Journal, 2019). After 8 weeks, assess the effect: if the dose works, continue. If there is no improvement, verify the dose, form, and cause of stress.

Does tolerance develop to CBD?

There is no hard evidence for classic pharmacological tolerance to CBD. The WHO review from 2018 indicates a good safety profile and lack of addictive potential (WHO ECDD, 2018). In some users, after 8-12 weeks, the subjective effect weakens, which is explained more by up-regulation of CB1 receptors and may require dose adjustment, not discontinuation.

Do breaks need to be taken in CBD use?

There are no mandatory breaks, but a 2-week reset window every 3-6 months helps assess the actual need for supplementation. WHO data from 2018 and the Frontiers in Pharmacology review from 2020 do not require cycling, but many clinicians recommend periodic discontinuation to verify the baseline anxiety state (Frontiers in Pharmacology, 2020).

What dose of CBD for social anxiety and public speaking?

In the RCT by Bergamaschi 2011, a dose of 600 mg at once reduced anxiety in individuals with social phobia in a simulated speaking test (Neuropsychopharmacology, 2011). Linares 2019 showed that 300 mg is optimal (Brazilian Journal of Psychiatry, 2019). In practice, 50-150 mg 60-90 minutes before the event is a safe start for someone without experience.

Can CBD be combined with anxiolytics?

CBD inhibits the enzymes CYP3A4 and CYP2C19, which metabolize, among others, SSRIs, benzodiazepines, and some sleeping medications (PMC, 2019). Combining requires consultation with a doctor, as it may raise the concentration of the drug in the blood. In practice, a 2-hour interval between CBD and medication reduces the risk of interactions but does not eliminate it.

Which oil to choose to start: 5% or 10%?

For starting, a concentration of 5% (500 mg in 10 ml) is recommended. One drop contains about 2.5 mg of CBD, allowing precise dosing of 10-25 mg daily. Oil 10% (1000 mg in 10 ml) makes sense when the target dose exceeds 30 mg, to limit the number of drops and cost per milligram.

Does CBD lower cortisol?

In the 1993 study by Zuardi, 300 and 600 mg of CBD reduced serum cortisol levels in healthy volunteers (Psychopharmacology, 1993). Later works confirm the modulation of the HPA axis by CBD, although the effect depends on the dose and time of day. This is one of the mechanisms explaining the anxiolytic action of CBD.

Summary – how to approach CBD for stress wisely?

The practical CBD protocol for stress is based on four pillars. First, a starting dose of 25 mg daily divided into morning and evening, sublingually. Second, titration every 5-7 days by 10-15 mg if the effect is insufficient, within a window up to 75 mg daily without medical supervision. Third, 4-8 weeks of regular use as an assessment window for effect. Fourth, response signals in 5 areas: sleep, morning tension, reactivity, tolerance of uncertainty, recovery.

CBD is not a panacea, but it is a real, well-researched support tool for individuals with moderate chronic stress and situational anxiety. The safety profile is good, and the risk of drug interactions should be consulted with a doctor. The absence of classic tolerance means that long-term use does not require dose escalation.

If you are starting, choose a 5% broad-spectrum oil as a proven starting form. After 4-8 weeks, assess the effect based on objective criteria, not just intuition. You can find the full range of CBD oils in our the u Bucha store, and the scientific data supporting the protocols in the section scientific research.

This article is for informational and educational purposes and does not constitute medical advice. CBD is not a medicine and does not replace psychiatric or psychological treatment. Before starting supplementation, especially if you are taking other medications, are pregnant, breastfeeding, have chronic illnesses, or mental disorders, consult your doctor. In cases of severe anxiety, panic attacks, or depression, do not rely solely on supplementation – contact a psychiatrist or psychotherapist.

Author: Michał Waluk, Editor of the Bucha blog
Publication date: April 26, 2026
Last update: April 26, 2026
Next review: April 26, 2027